 
 

 

 
  
 
 
  

ﬂ, BIOPSY -
I M (0/1) (see comment).

#2, BIOPSY -

OMY T 11 O'CLOCK -
NOTerlNGHAM GRADE 3/3 (TUBULE SCORE 3, NUCLEAR GRADE 3,
I ' ‘ , __ 19) (see comment).

3. ALL moms AREIESA on NEOPLASM.

C. TUMOR SIZE IS 1.3 CM IN GREATEST DIMENSION (gross measurement).

D. DEFINITE ANGIOLYMPHATIC INVASION IS NOT IDENTIFIED.

E. BIOPSY SITE CHANGES.
F. FIBROCYSTIC CHANGES, COLUMNAR CELL CHANGE, AND PSEUDOANGIOMATOUS STROMAL

 

  
 
  
    

 

HYPERPLASIA (PASH). ,_‘_c ,
CASE SYNOP : ’ “T ‘ ‘ ' ' "" ‘
SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST
LATERALITY: Right
PROCEDURE: Segmental ‘
LOCATION: Upper outer quadrant
SIZE OF TUMOR: Maximum dimension invasive component: 1.3 cm
MULTICENTRICITYIMULTIFOCALITY OF INVASIVE FOCI:
No
TUMOR TYPE (invasive component): / C A , ﬂ ,3
Ductal adenocarcinoma. NOS _
NOTTINGHAM scone: Nuclear grade: 3 5mm] WW MW ffao/g
Tubule formation: 3
Mitotic activity score: 3 5m: W N05 050' 7 3/’3///
Total Nottingham score: 9 ' A“

Nottingham grade (1, 2, 3): 3

ANGIOLYMPHATIC INVASION: No

DERMAL LYMPHATIC INVASION: Not applicable

CALCIFICATION: No

SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT:
No

Distance of invasive tumor to closest margin: 8 mm
LYMPH NODES POSITIVE:

LYMPH NODES EXAMINED: 2
METHODIS) OF LYMPH NODE EXAMINATION:

HIE stain, Keratin stain
No

SENTINEL NODE METASTASIS:
NON-NEOPLASTIC BREAST TISSUE: FCD, Other: columnar cell change and PASH
T STAGE, PATHOLOGIC: pT1c

N STAGE. PATHOLOGIC: pNO

M STAGE, PATHOLOGIC: pMX

ESTROGEN RECEPTORS: unknown

PROGESTERONE RECEPTORS: unknown
HERZ/NEU: unknOWn

 

. camco
uum-unenzsa-acEA-naas-Aoaa 07m Redacted

GA- H-AO L-B‘lA-PR
lllllll lllTIllllllrlllllllfllllllllllllllllllllllllllllllllllllllll
ll llll lull

‘ I||||l|l||l|
Illlllllllllll ll llllllllll
ll‘lllll} llllllpllllul‘lllllllllllllllllllll|||||||||||||||||lllllll

